Term ends no later than Aug 17, 2040 · Medium confidence
20-year base term ends Jun 26, 2040
In force on USPTO's status record and by its fee record. A terminal disclaimer on file may shorten this term, possibly to a date already past; its reference document is unresolved, so the date above is an upper bound and no earlier date is guessed.
Jun 26, 2020
Aug 17, 2040
Jun 25, 2024
This patent's term runs 52 days past its 20-year base term on prosecution delay. A terminal disclaimer is on file with no resolved reference, so no cap is applied and none is guessed. 0 of 3 maintenance fees are paid so far. Confidence: Medium. from the record
How we calculated this date
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Jun 26, 2020, when application PCT/AU2020/050660, the earliest non-provisional in its chain, was filed (this one was filed Mar 23, 2023) | Jun 26, 2040 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +52 days, USPTO patent term adjustment record | Aug 17, 2040 | High confidence |
| Terminal disclaimer cap | Disclaimer on file (approved), reference document not resolved | no cap applied, and none guessed | Medium confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 0 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | no later than Aug 17, 2040 | Medium confidence |
Partial family
| Application PCT/AU2020/050660 | PCT application no patent term | no patent term |
| US 12,709,596 | In force Aug 2040 | Aug 2040 |
| US 12,017,979 | this patent no later than Aug 2040 | no later than Aug 2040 |
Assignments
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Aug 16, 2023 Reel 64609, frame 468 | Holmes, Ian | BCP3 Pty Ltd. | Assignment of Assignor's Interest |
| Aug 16, 2023 Reel 64610, frame 437 | BCP3 Pty Ltd. | Ena Therapeutics Pty Ltd. | Assignment of Assignor's Interest |
| Aug 16, 2023 Reel 64612, frame 213 | The University of Melbourne | Ena Therapeutics Pty Ltd. | Assignment of Assignor's Interest |
| Aug 16, 2023 Reel 64612, frame 385 | Jackson, David; Demaison, Christophe | Ena Therapeutics Pty Ltd. | Assignment of Assignor's Interest |
| Aug 16, 2023 Reel 64615, frame 302 | Zeng, Weiguang | The University of Melbourne | Assignment of Assignor's Interest |
| Aug 17, 2023 Reel 64618, frame 540 | McLachlan, Grant | Axelia Oncology Pty Ltd. Of | Assignment of Assignor's Interest |
| Aug 17, 2023 Reel 64618, frame 546 | Axelia Oncology Pty Ltd. | Ena Respiratory Pty Ltd. | Assignment of Assignor's Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
What's changing
A terminal disclaimer is on file (approved) and its reference document is not resolved. A disclaimer would cap the term earlier than Aug 17, 2040. We will not guess the cap.